We recently compiled a list of the 10 Best Stocks Under $3 to Buy Now. In this article, we are going to take a look at where OPKO Health, Inc. (NASDAQ:OPK) stands against the other stocks under $3.
Investors are grappling with Trump-fueled stock market volatility in 2025. On March 12, 2025, Yahoo Finance reported that Penny Pennington, CEO of Edward Jones, explained on Yahoo Finance’s Opening Bid podcast that this volatility should have been expected. She noted that after years of relatively calm markets where we didn’t see the usual pullbacks, typically ranging from 5% to 15%. She further pointed out that the current environment, marked with uncertainties from tariffs and policy changes, is bound to provoke market reactions.
READ ALSO: 8 Fastest Growing AI Stocks To Buy Right Now and 10 Cheap Technology Stocks to Buy According to Hedge Funds.
The markets have been particularly volatile this year due to concerns about tariffs and potential economic slowdowns. The market has taken a hit, with the Dow Jones Industrial Average, S&P 500, and Nasdaq Composite all dropping around 5% on average in March alone. Large-cap tech companies have led this downturn. For the year, the Nasdaq has declined nearly 10%, the S&P 500 by 6%, and the Dow by 3%.
Recent economic data for consumer confidence from the Dallas Fed survey highlights growing caution among consumers and businesses. This has further fueled volatility as markets adjust to a potential slowdown in growth.
Pennington’s advice to investors is to stay prepared for several more years of volatility under the Trump administration.
The mix of policy uncertainty, tariff impacts, and inflation concerns has created a volatile environment, and this is likely to continue. Despite these concerns, some penny stocks continue to attract attention for their promising prospects.
Methodology
To compile our list of the 10 best stocks under $3 to buy now, we used the Finviz stock screener. We sorted our results based on market capitalization and picked the top 20 companies with a share price of under $3 as of March 10, 2025. Next, we focused on the top 10 stocks most favored by institutional investors. Data for the hedge fund sentiment surrounding each stock was taken from Insider Monkey’s Q4 2024 database of more than 1,000 elite hedge funds. Finally, the 10 best stocks under $3 to buy now were ranked in ascending order based on the number of hedge funds holding stakes in them as of Q4 2024.
Why do we care about what hedge funds do? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (see more details here).
A doctor in scrubs discussing a patient’s test results with a small group of concerned family members.
OPKO Health, Inc. (NASDAQ:OPK)
Share Price: $1.84
Number of Hedge Fund Holders: 22
OPKO Health, Inc. (NASDAQ:OPK) is a multinational company that is focused on diagnostics and biopharmaceuticals. The company has operations in the US, Mexico, Chile, Spain, Ireland, and Israel. OPKO Health, Inc.’s (NASDAQ:OPK) marketed therapies are sold throughout the world thanks to the company’s commercial partnerships with global pharmaceutical companies. OPK is one of the best stocks under $3 to invest in.
The company is currently focused on streamlining operations and enhancing financial flexibility through a series of transactions to support its long-term growth plans. In 2024, OPKO Health, Inc. (NASDAQ:OPK) successfully reduced its common share count by 81 million shares or 10% of shares outstanding. The company also generated $166.6 million from selling GeneDx shares, with an additional $51.7 million received after December 31, 2024. In September 2024, OPKO Health, Inc. (NASDAQ:OPK) sold a portion of BioReference Health’s laboratory testing businesses focused on clinical diagnostics and women’s health for a purchase price of $237.5 million. More recently, on March 11, 2025, OPKO Health, Inc. (NASDAQ:OPK) announced an agreement for Labcorp to acquire select assets of BioReference Health for up to $225 million, including $192.5 million at closing and $32.5 million in an earnout based on performance. These moves aim to help the company simplify its operations and improve its financial position.
Overall, OPK ranks 7th on our list of the best stocks under $3 to buy now. While we acknowledge the potential of OPK as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than OPK but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.
READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.
Disclosure: None. This article is originally published at Insider Monkey.